Page last updated: 2024-10-28

hydroxyurea and AIDS Dementia Complex

hydroxyurea has been researched along with AIDS Dementia Complex in 1 studies

AIDS Dementia Complex: A neurologic condition associated with the ACQUIRED IMMUNODEFICIENCY SYNDROME and characterized by impaired concentration and memory, slowness of hand movements, ATAXIA, incontinence, apathy, and gait difficulties associated with HIV-1 viral infection of the central nervous system. Pathologic examination of the brain reveals white matter rarefaction, perivascular infiltrates of lymphocytes, foamy macrophages, and multinucleated giant cells. (From Adams et al., Principles of Neurology, 6th ed, pp760-1; N Engl J Med, 1995 Apr 6;332(14):934-40)

Research Excerpts

ExcerptRelevanceReference
"Hydroxyurea has been shown to potentiate the activity of the antiretroviral nucleoside analogs."1.32Pharmacokinetics of hydroxyurea in plasma and cerebrospinal fluid of HIV-1-infected patients. ( Gwilt, PR; Manouilov, KK; McNabb, J; Swindells, SS, 2003)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gwilt, PR1
Manouilov, KK1
McNabb, J1
Swindells, SS1

Other Studies

1 other study available for hydroxyurea and AIDS Dementia Complex

ArticleYear
Pharmacokinetics of hydroxyurea in plasma and cerebrospinal fluid of HIV-1-infected patients.
    Journal of clinical pharmacology, 2003, Volume: 43, Issue:9

    Topics: Administration, Oral; Adult; AIDS Dementia Complex; Anti-HIV Agents; Anti-Retroviral Agents; Chromat

2003